Arcus Biosciences, Inc. (RCUS)
23.22
-0.10
(-0.45%)
USD |
NYSE |
Dec 30, 16:00
23.22
0.00 (0.00%)
After-Hours: 20:00
Arcus Biosciences Market Cap: 2.874B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 152.84B |
| Actinium Pharmaceuticals, Inc. | 43.05M |
| Madrigal Pharmaceuticals, Inc. | 13.26B |
| Karyopharm Therapeutics, Inc. | 124.49M |
| Janux Therapeutics, Inc. | 832.14M |
Market Cap Related Metrics
| PS Ratio | 9.752 |
| PEG Ratio | -0.7707 |
| Price to Book Value | 6.591 |
| Price | 23.22 |
| Earnings Yield | -14.77% |
| PEGY Ratio | -0.7707 |